Catalina Capital Group, LLC Merck & Co., Inc. Transaction History
Catalina Capital Group, LLC
- $153 Billion
- Q1 2025
A detailed history of Catalina Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 2,570 shares of MRK stock, worth $206,422. This represents 0.15% of its overall portfolio holdings.
Number of Shares
2,570
Previous 10,323
75.1%
Holding current value
$206,422
Previous $1.03 Billion
77.53%
% of portfolio
0.15%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,896Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.68 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.56 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.79 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...